论著

置入胰管支架对ERCP取石联合ERBD术后肝外胆管结石复发的影响因素分析

  • 王玉彬 ,
  • 张红雷 ,
  • 张诚 ,
  • 孔祥余 ,
  • 项羽凯 ,
  • 杨玉龙
展开
  • 1 同济大学医学院, 上海 200331
    2 同济大学附属东方医院胆石病中心, 上海 200120
第一联系人:

王玉彬负责文献查阅、资料收集、统计数据和撰写;张红雷、张诚负责资料收集;孔祥余负责数据核验;项雨凯负责修订;杨玉龙负责指导、审查和修订。所有作者均阅读并确认最终稿。

杨玉龙,E-mail: yyl516@tongji.edu.cn

收稿日期: 2025-10-12

  网络出版日期: 2026-09-28

Analysis of influencing factors of placement of pancreatic duct stent on recurrence of extrahepatic bile duct stones after ERCP lithotomy combined with ERBD

  • WANG Yubin ,
  • ZHANG Honglei ,
  • ZHANG Cheng ,
  • KONG Xiangyu ,
  • XIANG Yukai ,
  • YANG Yulong
Expand
  • 1 Tongji University School of Medicine, Shanghai 200331, China
    2 Center of Gallstone Disease, Shanghai East Hospital, Tongji University, Shanghai 200120, China

Received date: 2025-10-12

  Online published: 2026-09-28

摘要

目的:探讨胰管支架对内镜逆行胰胆管造影(ERCP)取石联合内镜逆行胆管引流(ERBD)术后肝外胆管结石远期复发的影响,为临床治疗与预防提供参考。方法:纳入2019年4月至2024年8月接受ERCP取石+ERBD治疗的366例肝外胆管结石病人,按是否接受ERPD分为研究组与对照组,随访并比较复发情况。采用倾向评分匹配法(PSM)消除混杂偏倚,通过Kaplan-Meier生存曲线及COX回归分析影响因素。结果:共366例病人中位随访13.8(6.2, 29.8)个月,复发13例(3.6%)。PSM后Kaplan-Meier生存曲线显示,研究组复发风险显著降低(HR=0.092, 95%CI: 0.012~0.716,P=0.004)。COX回归分析显示,十二指肠乳头长度>8 mm(HR=4.04, 95%CI: 1.13~14.45, P=0.032)、结石类型(HR=0.10, 95%CI: 0.01~0.85, P=0.035)和ERPD(HR=0.04, 95%CI: 0.00~0.72, P=0.029)为独立影响因素。结论:ERPD是ERCP取石并ERBD术后肝外胆管结石远期复发的独立保护因素,十二指肠乳头长度>8 mm为危险因素,块状肝外胆管结石较泥沙样结石复发风险低。

本文引用格式

王玉彬 , 张红雷 , 张诚 , 孔祥余 , 项羽凯 , 杨玉龙 . 置入胰管支架对ERCP取石联合ERBD术后肝外胆管结石复发的影响因素分析[J]. 外科理论与实践, 2026 , 31(04) : 326 -334 . DOI: 10.16139/j.1007-9610.2026.04.07

Abstract

Objective To investigate the impact of pancreatic duct stent on long-term recurrence of extrahepatic bile duct stones after endoscopic retrograde cholangiopancreatography (ERCP) lithotomy combined with endoscopic retrograde biliary drainage (ERBD), and to provide clinical reference for treating patients with extrahepatic bile duct stones and preventing stone recurrence. Methods A total of 366 patients with extrahepatic bile duct stones treated by ERCP lithotomy and ERBD between April 2019 and August 2024 were enrolled and followed up. The patients were divided into a research group and a control group according to whether received ERPD. Recurrence outcomes were collected and compared between the two groups. Propensity score matching (PSM) was used to eliminate confounding bias, followed by Kaplan-Meier survival curve generation. COX regression analysis was performed to analyze the influencing factors. Results A total of 366 patients were included, with a median follow-up duration of 13.8 (6.2, 29.8) months. Thirteen cases (3.6%) developed recurrence. After PSM, the Kaplan-Meier survival curve showed the recurrence risk of the research group was significantly reduced (HR=0.092, 95%CI: 0.012-0.716, P=0.004). COX regression analysis revealed that duodenal papilla length>8 mm (HR=4.04, 95%CI: 1.13-14.45, P=0.032), stone type (HR=0.10, 95%CI: 0.01-0.85, P=0.035), and ERPD (HR=0.04, 95%CI: 0.00-0.72, P=0.029) were independent influencing factors. Conclusions ERPD is an independent protective factor against long-term recurrence of extrahepatic bile duct stones after ERCP lithotomy and ERBD. A duodenal papilla length>8 mm is an independent risk factor. Block extrahepatic bile duct stones have a lower long-term recurrence risk than silt-like stones.

参考文献

[1] Sayeed M S, Sharma S, Rajput J P S, et al. Therapeutic endoscopic interventions in choledocholithiasis:efficacy of endoscopic retrograde cholangiopancreatography[J]. Cureus, 2025, 17(1):e76955.
[2] 中华医学会外科学分会胆道外科学组. 急性胆道系统感染的诊断和治疗指南(2021版)[J]. 中华外科杂志, 2021, 59(6):422-429.
  Biliary Surgery Group, Chinese Society of Surgery, Chinese Medical Association. Guidelines for diagnosis and treatment of acute biliary tract infections(2021)[J]. Chin J Surg, 2021, 59(6):422-429.
[3] Prat F, Malak N A, Pelletier G, et al. Biliary symptoms and complications more than 8 years after endoscopic sphincterotomy for choledocholithiasis[J]. Gastroenterology, 1996, 110(3):894-899.
[4] 石玉琪, 许春芳. ERCP联合腹腔镜胆囊切除术治疗胆总管结石合并胆囊结石术后胆总管结石复发的危险因素分析[J]. 中华消化内镜杂志, 2016, 33(10):689-692.
  Shi Yuqi, Xu Chunfang. Risk factors for common bile duct stones recurrence in patients undergoing ERCP and LC[J]. Chin J Digest Endos, 2016, 33(10):689-692.
[5] Huang P, Yang H, Kuang H, et al. Pancreaticobiliary maljunction:a multidimensional exploration of pathophysio-logy, diagnosis, classification, management and research prospects[J]. Dig Dis Sci, 2025, 70(6):1966-1975.
[6] Lin Y, Yang M, Cao J, et al. Saline irrigation for reducing the recurrence of common bile duct stones after lithotripsy: a randomized controlled trial[J]. EClinicalMedicine, 2023, 59:101978.
[7] 张诚, 杨玉龙. 从胆胰管汇合部疾病分析认识胆石病的内镜治疗[J]. 外科理论与实践, 2023, 28(2):119-123.
  Zhang Cheng, Yang Yulong. Analysis and recognition of endoscopic treatment for cholelithiasis from the view of disease of pancreaticobiliary junction[J]. J Surg Concepts Pract, 2023, 28(2):119-123.
[8] 张诚, 杨玉龙. 重视胆胰管汇合部疾病的内镜诊治[J]. 中华医学杂志, 2022, 102(18):1326-1329.
  Zhang Cheng, Yang Yulong. Pay attention to endoscopic diagnosis and treatment for confluence disease of pancreaticobi-liary ducts[J]. Natl Med J China, 2022, 102(18):1326-1329.
[9] Fujita N, Yasuda I, Endo I, et al. Evidence-based clinical practice guidelines for cholelithiasis 2021[J]. J Gastroenterol, 2023, 58(9):801-833.
[10] Hayashi S, Ito Y, Higashi R. Cap-fitted ultrathin endoscope-assisted endoscopic retrograde cholangiopancreatography (ERCP) for patients with hidden papillae in duodenal diverticula[J]. J Hepatobiliary Pancreat Sci, 2024, 31(7):e41-e43.
[11] Wen N, Wang Y, Cai Y, et al. Risk factors for recurrent common bile duct stones: a systematic review and meta-analysis[J]. Expert Rev Gastroenterol Hepatol, 2023, 17(9):937-947.
[12] Cotton P B, Lehman G, Vennes J, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus[J]. Gastrointest Endosc, 1991, 37(3):383-393.
[13] Archibugi L, Mariani A, Traini M, et al. “Delayed” needle-knife fistulotomy versus standard biliary sphincterotomy for choledocholithiasis: recurrence of common bile duct stones and rate of post-ERCP pancreatitis[J]. Endosc Int Open, 2019, 7(12):E1733-E1741.
[14] 赖晓伟, 周玮, 刘杰, 等. 胆总管结石内镜治疗复发的危险因素分析[J]. 中华消化内镜杂志, 2015, 2015(9):600-603.
  Lai Xiaowei, Zhou Wei, Liu Jie, et al. Risk factors for recurrence after endoscopic treatment of common bile duct stones[J]. Chin J Digest Endosc, 2015, 2015(9):600-603.
[15] Sotoudehmanesh R, Ali-Asgari A, Khatibian M, et al. Pharmacological prophylaxis versus pancreatic duct stenting plus pharmacological prophylaxis for prevention of post-ERCP pancreatitis in high risk patients: a randomized trial[J]. Endoscopy, 2019, 51(10):915-921.
[16] Tang D, Gu J, Ao Y, et al. Clinical efficacy of endoscopic retrograde cholangiopancreatography in the treatment of acute biliary pancreatitis: a meta-analysis[J]. Wideochir Inne Tech Maloinwazyjne, 2022, 17(4):561-578.
[17] 中国医师协会内镜医师分会内镜微创保胆专业委员会, 胆胰管汇合部良性疾病内镜诊治专家共识协作组. 胆胰管汇合部良性疾病内镜诊治专家共识(2023版)[J]. 中华医学杂志, 2023, 103(40):3174-3179.
  The Gallbladder-Preserving Surgery Committee, Endoscopy Specialist Branch of Chinese Medical Doctor Association; Expert Consensus Collaborative Group on Endoscopic Diagnosis and Treatment of the Benign Pancreaticobiliary Junction Disease. Expert consensus on endoscopic diagnosis and treatment of the benign pancreaticobiliary junction disease (2023 edition)[J]. Natl Med J China, 2023, 103(40):3174-3179.
[18] BeltráN M A, BeltráN A A. Common bile duct pressure in patients with and without cholelithiasis: a case-control study[J]. J Hepatobiliary Pancreat Sci, 2021, 28(5):443-449.
[19] Kim D B, Paik C N, Song D S, et al. The role of endoscopic ultrasonography and magnetic resonance cholangiopancreatography in patients with acute pancreatitis after negative computed tomography findings of the etiology[J]. Pancreas, 2018, 47(9):1165-1171.
[20] Tari E, Gagyi E B, Rancz A, et al. Morphology of the papilla can predict procedural safety and efficacy of ERCP-a systematic review and meta-analysis[J]. Scientific reports, 2024, 14(1):7341.
[21] 王爱东, 陈志红, 张法标, 等. 十二指肠乳头生理性过长致胆胰管梗阻病变的内镜诊断与治疗[J]. 肝胆胰外科杂志, 2011, 23(1):15-17.
  Wang Aidong, Chen Zhihong, Zhang Fabiao, et al. Role of endoscope in diagnosis and treatment of the pancreatobiliary obstructive diseases induced by physiologically overlengthed papilla[J]. J Hepatopancreatobiliary Surg, 2011, 23(1):15-17.
[22] Liu L, Zhao Z, Hou X, et al. Effect of sphincter of oddi dysfunction on the abundance of biliary microbiota (biliary microecology) in patients with common bile duct stones[J]. Front Cell Infect Microbiol, 2022, 12:1001441.
[23] Kim B, Park J S, Bae J, et al. Bile microbiota in patients with pigment common bile duct stones[J]. J Korean Med Sci, 2021, 36(15):e94.
[24] Baek S M, Lee A R, Lee S W, et al. Intrahepatic cholelithiasis with gallbladder-like metaplasia of intrahepatic bile ducts associated with gallbladder agenesis in a wild boar[J]. J Vet Diagn Invest, 2023, 35(4):390-394.
[25] Yoo E S, Yoo B M, Kim J H, et al. Evaluation of risk factors for recurrent primary common bile duct stone in patients with cholecystectomy[J]. Scand J Gastroenterol, 2018, 53(4):466-470.
[26] Jiang Y H, Zhang A H, Zhou S J. Pancreatogenic choledocholithiasis in common bile duct stump after Roux-en-Y hepaticojejunostomy: a case report[J]. Medicine, 2017, 96(46):e8789.
[27] 叶连松. 胆总管结石患者ERCP术后胆管炎和结石复发的预防及机制初探[D]. 四川: 四川大学, 2021.
  Ye Liansong. Prevention and preliminary mechanisminvesti-gation for post-ERCP cholangitis andstone recurrence in patients withcholedocholithiasis[D]. Sichuan: Sichuan University, 2021.
[28] Kaneko J, Kawata K, Watanabe S, et al. Clinical characteristics and risk factors for stent-stone complex formation following biliary plastic stent placement in patients with common bile duct stones(Article)[J]. J Hepatobiliary Pancreat Sci, 2018, 25(10):448-454.
[29] Manes G, Paspatis G, Aabakken L, et al. Endoscopic management of common bile duct stones: European Society of Gastrointestinal Endoscopy (ESGE) guideline[J]. Endoscopy, 2019, 51(5):472-491.
[30] Li X, Zhu K, Zhang L, et al. Periampullary diverticulum may be an important factor for the occurrence and recurrence of bile duct stones[J]. World J Surg, 2012, 36(11):2666-2669.
[31] Zheng H, Yan S, Li D, et al. Influence of periampullary diverticula on endoscopic retrograde cholangiopancreatography[J]. Exp Ther Med, 2021, 21(4):410.
[32] Lobo D N, Balfour T W, Iftikhar S Y, et al. Periampullary diverticula and pancreaticobiliary disease[J]. Br J Surg, 1999, 86(5):588-597.
[33] Ji X, Yang Z, Ma S R, et al. New common bile duct morphological subtypes: Risk predictors of common bile duct stone recurrence[J]. World J Gastrointest Surg, 2022, 14(3):236-246.
[34] Lujian P, Xianneng C, Lei Z. Risk factors of stone recurrence after endoscopic retrograde cholangiopancreatography for common bile duct stones[J]. Medicine, 2020, 99(27):e20412.
[35] Song M E, Chung M J, Lee D J, et al. Cholecystectomy for prevention of recurrence after endoscopic clearance of bile duct stones in Korea[J]. Yonsei Med J, 2016, 57(1):132-137.
[36] Keizman D, Shalom M I, Konikoff F M. An angulated common bile duct predisposes to recurrent symptomatic bile duct stones after endoscopic stone extraction[J]. Surg Endosc, 2006, 20(10):1594-1599.
[37] Park S Y, Hong T H, Lee S K, et al. Recurrence of common bile duct stones following laparoscopic common bile duct exploration: a multicenter study[J]. J Hepatobiliary Pancreat Sci, 2019, 26(12):578-82.
文章导航

/

〈 〉